Moderna, Inc. : melts like snow in the sun
By Odile Dubois
Two years ago, the Cambridge-based biotech reached a market capitalization of $100 billion after developing a vaccine against Covid in record time.
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
151 USD | -2.38% | +5.93% | +51.85% |
Jun. 08 | US FDA expands GSK's RSV vaccine approval to adults aged 50 to 59 | RE |
Jun. 07 | Moderna Files With FDA for Updated Covid Shot | DJ |
By Odile Dubois
Two years ago, the Cambridge-based biotech reached a market capitalization of $100 billion after developing a vaccine against Covid in record time.
Price
|
Change
|
5d. change
|
Capi.
| ||
---|---|---|---|---|---|
151 USD | -2.38% | +5.93% | 57.87B | ||
100.3 USD | -1.44% | -0.26% | 24.21B | ||
1st Jan change | Capi. | |
---|---|---|
+51.85% | 57.87B | |
+41.42% | 40.25B | |
-5.25% | 39.94B | |
-5.16% | 28.54B | |
+12.79% | 26.4B | |
-20.18% | 19.33B | |
+30.88% | 12.4B | |
+0.61% | 12.23B | |
+25.06% | 12.2B | |
-9.14% | 11.06B |